Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Decline in Whooping Cough Cases Continues

Published: Friday, May 16, 2014
Last Updated: Friday, May 16, 2014
Bookmark and Share
PHE publish whooping cough figures which are on a decline across England.

There were 4,623 laboratory confirmed cases of whooping cough (pertussis) in England in 2013, 51% fewer cases than in 2012 when 9,367 cases were reported, according to annual figures published by Public Health England (PHE).

Case numbers in infants under 3 months have proportionally seen the greatest reduction, with 79% fewer cases in 2013 (85 cases) than in 2012 (407 cases). There were 3 deaths in infants with whooping cough confirmed in 2013, compared to 14 deaths in 2012.

In September 2012 the Department of Health announced a temporary vaccination programme for pregnant women in response to an ongoing whooping cough outbreak. Pregnant women have been offered the whooping cough vaccine between 28 and 38 weeks of pregnancy since 1 October 2012.

Vaccinating against whooping cough in pregnancy enables the mother to transfer a high level of whooping cough antibodies (immunity) to her unborn child. This is to protect their baby against disease from birth until they receive their first dose of vaccine at 2 months of age.

Latest vaccine uptake figures in pregnant women show that around 60% have received their vaccination.

PHE’s head of immunization, Dr Mary Ramsay, said, “The continued reduction in cases of whooping cough in young infants is welcome news, but unfortunately we still confirmed the infection in three babies who died in 2013. The babies were too young to have been vaccinated themselves and none of their mothers had been vaccinated in pregnancy.

“The increase in vaccine uptake over the last 6 months is very encouraging but we need to ensure we vaccinate as many pregnant women as possible to avoid further tragic deaths. Although we have also seen a decline in cases in older children and adults between 2012 and 2013, the numbers still remain considerably higher than in 2011 suggesting that the infection is still circulating.

“While the infection remains at such high levels we are urging pregnant women to ensure they are vaccinated between 28 and 38 weeks of pregnancy. We are also working with GPs, midwives and other health professionals to ensure they have the facts at hand to help women make the decision to vaccinate.”

Whooping cough affects all ages and is highly infectious. Young infants are at highest risk of severe complications and death from whooping cough as babies do not complete vaccination until they are around four months old. In older children and adults whooping cough can be an unpleasant illness but it does not usually lead to serious complications.

Dr Ramsay, continues, “Parents should also be alert to the signs and symptoms of whooping cough - which include severe coughing fits which may be accompanied by difficulty breathing (or pauses in breathing in young infants) or vomiting after coughing and the characteristic “whoop” sound in young children or may present as a prolonged cough in older children or adults.”

“Parents must also ensure their children are vaccinated against whooping cough on time, even babies of women who’ve had the vaccine in pregnancy - this is to continue their baby’s protection through childhood.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!